🇺🇸 Short selling in United States, Q4 2024

From 15 Oct 2024 to 31 Dec 2024, 4,295 United States companies carried disclosed short positions. The quarter's highest single reading was Nxu, Inc. at 76.49% on 29 Nov 2024. 87 companies appeared in the data for the first time. 102 left it. Figures are disclosed positions from official FINRA data.

← Q3 2024 Q1 2025 →

Cite this page

Plain

Short position data for Short selling in United States, Q4 2024: FINRA, compiled by howshorted.com, settlement date 31 Dec 2024. https://howshorted.com/us/review/2024-q4/

Wikipedia

<ref>{{cite web |title=Short selling in United States, Q4 2024 short position data |url=https://howshorted.com/us/review/2024-q4/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2024-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-short-selling-in-united-states-q4-2024-2024-12-31,
  title        = {Short selling in United States, Q4 2024 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/review/2024-q4/}},
  note         = {Data: FINRA, settlement date 31 Dec 2024; accessed 2026-10-13},
  year         = {2024}
}

Biggest rises of the quarter

Gaxos.ai Inc.+23.75pp to 27.02%
FARADAY FUTURE INTELLIGENT ELECTRIC INC.+21.81pp to 38.13%
Cyngn Inc.+15.54pp to 21.47%
Protara Therapeutics, Inc.+13.48pp to 24.72%
Syndax Pharmaceuticals Inc+12.70pp to 25.05%

Biggest falls of the quarter

Nxu, Inc.−17.40pp to 59.09%
1847 Holdings LLC−9.74pp to 5.66%
Nikola Corporation−9.55pp to 16.20%
Genprex, Inc.−9.38pp to 4.66%
Longboard Pharmaceuticals, Inc.−9.22pp to 4.07%

Changes compare each company's last figure of the quarter with its first; companies with a single report in the quarter are counted but not ranked. Where disclosure thresholds apply the figures are floors, not a census. Nothing here is investment advice.